Delivery Order SPE2DB22D2211-SPE2DB24FNEM3

Award Date 4/11/24
Potential Completion Date 4/12/24
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,703.00 firm fixed-price delivery order contract is for the supply of NAFTIFINE HCL 1% CREAM 90GM. The contract has an ultimate completion date of January 3, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
The provided information details a federal contract award made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,389.08 firm fixed-price delivery order contract is for the provision of NAFTIFINE HCL 1% cream, a pharmaceutical product. This contract appears to be part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,319.28 firm fixed price delivery order is for the supply of NAFTIFINE HCL 1% CREAM 60GM, a pharmaceutical product. The contract has an ultimate completion date of February 25, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $4,339.08, and has a completion date of November 6, 2024. The contract is for the procurement of NAFTIFINE HCL 1% CREAM 60GM, a medical product. There is no set-aside designation indicated for this award....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of NAFTIFINE HCL 2% cream in 45 gram tubes, with a total ceiling value of $1,149.90 and a completion date of December 29, 2023. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
This federal contract award, with ID SPE2DB24D2205|SPE2DB25FDYQT, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,725.26 firm fixed-price delivery order is for the supply of NAFTIFINE HCL 1% CREAM 60GM, a pharmaceutical product. The contract has an ultimate completion date of February 21, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Naftifine HCL 2% cream. The $3,620.20 contract has a completion date of May 26, 2022 and was awarded on May 25, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical for a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order valued at $1,873.54 for the supply of 4556611118 - Naftifine HCL 1% Cream 60GM. The contract has an ultimate completion date of March 21, 2022 and was awarded on March 18, 2022 under a Firm Fixed Price pricing type. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
The U.S. government agency, the Defense Logistics Agency (DLA) Troop Support Medical, awarded a $5,778.20 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565745808 - Naftifine HCL 1% Cream 60GM. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical, which allows the agency to efficiently procure a comprehensive range of medical commodities,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,129.11 firm fixed-price delivery order is for the supply of NAFTIFINE HCL 2% GEL 60GM, a topical antifungal medication. The contract has a period of performance through February 28, 2025 and is not associated with any set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB24FNEM3
    Delivery Order

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The $1,889.68 award is for the supply of 4564249290 - NAFTIFINE HCL 1% CREAM 60GM, a pharmaceutical product. The order has an ultimate completion date of April 12, 2024.

AmerisourceBergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This IDC does not have any set-aside designations.

Generated 7/11/24, 10:09 AM